Inflammatory Th17 cells and their associated cytokines (i.e., IL-17A, IL-17F, IL-21, IL-22, etc.)mediate tumor growth in two distinct ways – by driving angiogenesis and by suppressing antitumor immunity (86). The gene discussed is IL22; the disease is neoplasm.